Serhat Aras | Health Professions | Best Researcher Award

Posted on 30/10/202430/10/2024 by ScienceFather

Assoc. Prof. Dr. Serhat Aras | Health Professions | Best Researcher Award

Assoc. Prof. Dr. Serhat Aras, University of Health Sciences Turkey, Turkey

Assoc. Prof. Dr. Serhat Aras is a nuclear physicist with a Ph.D. from Manisa Celal Bayar University, where he focused on Monte Carlo methods in dose calculations for prostate brachytherapy. He currently serves at the University of Health Sciences, Istanbul, specializing in medical imaging and radiological sciences. Dr. Aras has led research on the radiobiological effects of advanced radiation techniques in cancer treatments, including studies on breast and lung cancer. His teaching includes courses on radiologic imaging, radiation safety, and nuclear medicine. In 2023, he received an International Research Award in India. 🧪📡👨‍🏫

Publication Profile

Google Scholar

Academic Background

Dr. Aras completed his PhD in Nuclear Physics at Celal Bayar University, focusing on advanced methodologies for calculating patient doses in prostate brachytherapy using Monte Carlo simulations. His Master’s research also focused on dose distribution in brachytherapy, providing a solid foundation for his contributions to medical physics. His specialized education enhances his capacity to innovate in patient-specific dosimetry, an essential area in clinical radiotherapy.

Professional Experience

Dr. Aras serves in the Medical Imaging Techniques Program at Istanbul Health Sciences University. His roles have included Assistant Professor and Lecturer, where he has imparted his knowledge in courses such as Radiologic Imaging Physics, Radiation Safety, and Nuclear Medicine. His expertise in radiology and medical physics makes him an asset to the field, both in research and education, as he prepares future professionals in these highly technical fields.

Research Projects

Dr. Aras has led numerous research projects in radiobiology and oncology, demonstrating his commitment to advancing medical science. His projects include the study of radiobiological impacts on non-small cell lung cancer xenografts and the protective effects of melatonin and probiotics against radiation-induced tissue damage in experimental rat models. His role as a principal investigator in these studies reflects his leadership and research aptitude, focusing on innovative approaches to radiotherapy and radiation protection.

Awards and Recognition

Dr. Aras received the 2023 International Research Award from ISSN, India, which highlights his global research impact. This accolade, along with his publication record, underscores his contributions to nuclear and medical physics on an international level.

Conclusion

Assoc. Prof. Dr. Serhat Aras’s extensive research in medical imaging, radiotherapy, and radiobiological protection, combined with his teaching and leadership roles, makes him a suitable and commendable candidate for the Best Researcher Award. His contributions to nuclear physics applications in medicine reflect both a commitment to scientific advancement and a positive impact on clinical practices.

Publication Top Notes

Dosimetric comparison of three-dimensional conformal radiotherapy (3D-CRT) and intensity modulated radiotherapy techniques (IMRT) with radiotherapy dose simulations for left breast cancer 💉 – Cited by: 41, Year: 2019
Dosimetric comparison of superflab and specially prepared bolus materials used in radiotherapy practice 📏 – Cited by: 27, Year: 2020
The role of melatonin on acute thyroid damage induced by high dose rate X-ray in head and neck radiotherapy 🌙 – Cited by: 12, Year: 2021
Radioprotective effect of melatonin against radiotherapy-induced cerebral cortex and cerebellum damage in rat 🐭 – Cited by: 11, Year: 2020
Radiobiological comparison of flattening filter (FF) and flattening filter free (FFF) beam in rat laryngeal tissue 🔬 – Cited by: 8, Year: 2020
Home care for mastectomy patients 🏥 – Cited by: 0, Year: 2008
A survey study of radiation protection awareness among radiology technicians in Mogadishu, Somalia 🌍 – Cited by: 7, Year: 2020
Thoracic re-irradiation for locally recurrent lung cancer 🫁 – Cited by: 5, Year: 2016
The dosimetric comparison and evaluation of helical tomotherapy, volumetric-modulated arc radiotherapy (VMAT), step-and-shoot and sliding window radiotherapy techniques in breast cancer 💻 – Cited by: 4, Year: 2022
Effect of Flattening Filter and Flattening Filter Free beams on radiotherapy-induced peripheral blood cell damage ⚗️ – Cited by: 4, Year: 2021

Chiara Villa | Health Professions | Best Researcher Award

Posted on 29/08/202429/08/2024 by ScienceFather

Chiara Villa | Health Professions | Best Researcher Award

Dr Chiara Villa, INSTITUT COCHIN U1016 Inserm/CNRS/UMR-S8104 -Université de Paris, France

Dr. Chiara Villa appears to be a highly suitable candidate for the Best Researcher Award based on her extensive academic background, professional achievements, and research contributions. Here’s an evaluation based on key aspects of her career:

Publication profile

Orcid

Academic Qualifications 📚

Dr. Villa has an impressive academic foundation, starting with a Baccalauréat in science and Latin, and advancing to earn a Doctor of Medicine degree from the University of Pavia, Italy. Her specialization in Anatomical Pathology and a Ph.D. in Sciences underscore her deep commitment to advancing her knowledge and expertise. Her Ph.D. work focused on predictive factors in silent pituitary adenomas, a crucial area in pathology and endocrinology, demonstrating her specialized research capabilities.

Professional Experience 🏥

Her professional trajectory includes significant roles in various prestigious institutions, such as the Centre Hospitalier Sainte Anne and Hôpital Foch, Paris. Her positions have ranged from Praticien Attaché to Médecin Spécialiste in Cytology and Anatomical Pathology. These roles highlight her extensive experience in neuropathology and cytopathology, positioning her as a leader in her field.

Research Contributions and Publications 📑

Dr. Villa’s research contributions are notable, with numerous publications in high-impact journals covering various topics, including molecular prognostic factors in gastric carcinoma and immunological pathways in lung diseases. Her work on pituitary adenomas, including diagnostic and prognostic markers, has provided valuable insights into the management of these conditions. The range and depth of her publications reflect her influence in advancing medical knowledge and patient care.

Conference Presentations 🎤

Dr. Villa has been an invited speaker at several key international conferences, presenting on topics like histological prognostic factors in pituitary tumors and the role of AIP mutations in pituitary tumorigenesis. These invitations underscore her recognition as an expert in her field and her ability to contribute to scientific discourse on a global scale.

Conclusion 🌟

Dr. Chiara Villa’s combination of advanced academic credentials, extensive professional experience, and significant research contributions make her a highly deserving candidate for the Best Researcher Award. Her work has not only advanced understanding in the fields of pathology and endocrinology but also has practical implications for patient diagnosis and treatment.

Publication top notes

Germline loss-of-function<i>PAM</i>variants are enriched in subjects with pituitary hypersecretion

Corticotroph tumor progression speed after adrenalectomy

Molecular genetics and new classification of pituitary adenomas,Génétique moléculaire et nouvelle classification des adénomes hypophysaires

Outcome of giant pituitary tumors requiring surgery

Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study

Gagan Mathur | Medicine and Dentistry Award | Best Researcher Award

Posted on 29/08/202429/08/2024 by ScienceFather

Assoc Prof Dr. Gagan Mathur | Medicine and Dentistry Award | Best Researcher Award

Assoc Prof Dr. Gagan Mathur, University of California Irvine, United States

Assoc Prof Dr. Gagan Mathur: Candidate for Best Researcher Award Evaluation

Publication profile

Google Scholar

Employment History

Dr. Gagan Mathur is a highly experienced professional with a strong background in transfusion medicine and clinical pathology. Since December 2022, he has served as the Medical Director of Transfusion Medicine-Blood Bank at the University of California Irvine School of Medicine, where he also holds the role of Associate Program Director of the Pathology Residency Program. He has previously held prominent positions at the Children’s Hospital Los Angeles and Saint Luke’s Health System in Kansas City, demonstrating his leadership and expertise in managing complex medical and educational settings.

Post-Graduate Training and Education

Dr. Mathur’s rigorous academic background includes a fellowship in Transfusion Medicine/Blood Banking and a residency in Clinical Pathology at the University of Iowa Hospitals & Clinics. He also holds an MBA from the University of Iowa, which complements his medical expertise with business acumen. His foundational medical education was completed at Dr. S.N. Medical College in India.

Certifications and Licensure

Dr. Mathur is board-certified in both Transfusion Medicine/Blood Banking and Clinical Pathology by the American Board of Pathology. He holds medical licenses in California and previously held licenses in Missouri, Kansas, and Iowa. His certification as a Certified Physician Executive underscores his commitment to leadership in healthcare.

Awards and Distinctions

Dr. Mathur has been recognized for his contributions to medicine with numerous accolades, including being named a Top Pathologist by Best in California Magazine in 2023 and a multiple nominee for the Orange County Physician of Excellence award. His early recognition includes the Paul E. Strandjord Young Investigator Award and an Outstanding Reviewer award from a leading scientific journal.

Teaching and Mentoring

Dr. Mathur is actively involved in teaching and mentoring the next generation of medical professionals. He serves as an Associate Program Director and Chair of the Clinical Competency Committee in the Pathology Residency Program at UC Irvine. He also contributes as a faculty member in various transfusion medicine and blood banking courses for medical students, residents, fellows, and clinical laboratory scientist students.

Publication Top Notes

Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22 (Journal of Analytical Toxicology) – Cited by 206, 2014 🧪📊
Antibody testing for COVID-19: can it be used as a screening tool in areas with low prevalence? (American Journal of Clinical Pathology) – Cited by 90, 2020 🦠🔬
High clinical suspicion of donor‐derived disease leads to timely recognition and early intervention to treat solid organ transplant‐transmitted lymphocytic choriomeningitis virus (Transplant Infectious Disease) – Cited by 29, 2017 🏥🦠
Use of a data warehouse at an academic medical center for clinical pathology quality improvement, education, and research (Journal of Pathology Informatics) – Cited by 25, 2015 📈🧑‍💻
Clinical profile and mortality among novel influenza A (H1N1) infected patients: 2009-2010 Jodhpur, Rajasthan pandemic (Journal of the Association of Physicians of India) – Cited by 25, 2013 🏥🌍
Antibody testing for COVID-19 (American Journal of Clinical Pathology) – Cited by 7, 2020 🦠🧬
Factors influencing platelet clumping during peripheral blood hematopoietic stem cell collection (Transfusion) – Cited by 7, 2017 🩸🔬
A clinico-epidemiologic study of neurologic associations and factors related to speech and language delay (National Journal of Community Medicine) – Cited by 7, 2012 🧠🗣️
Solutions to technical challenges during therapeutic plasma exchange using the Spectra Optia on a 4 kilogram neonate (Transfusion and Apheresis Science) – Cited by 5, 2018 🍼🩸
Streamlined sign-out of capillary protein electrophoresis using middleware and an open-source macro application (Journal of Pathology Informatics) – Cited by 5, 2014 🧬💻
A case for a national registry of red blood cell antibodies (Vox Sanguinis) – Cited by 4, 2022 🩸🧾
Predicting changes in hemoglobin S after simple transfusion using complete blood counts (Transfusion) – Cited by 3, 2018 🩸🧪
A case cluster of lymphocytic choriomeningitis virus transmitted via organ transplantation (Transplantation) – Cited by 2, 2014 🦠🏥

Conclusion

Assoc Prof Dr. Gagan Mathur’s extensive experience, academic background, and leadership roles make him a strong candidate for the Best Researcher Award. His contributions to transfusion medicine, combined with his teaching and mentoring roles, demonstrate a commitment to advancing medical science and education. His recognition by peers and multiple accolades further support his suitability for this prestigious award

Nastaran Heydarikhayat | Health Professions Award | Best Researcher Award

Posted on 19/06/202419/06/2024 by ScienceFather

Dr. Nastaran Heydarikhayat | Health Professions Award | Best Researcher Award

Dr. Nastaran Heydarikhayat, Iranshahr University of Medical Sciences, Iran

Dr. Nastaran Heydarikhayat is a distinguished faculty member at Iranshahr University of Medical Sciences, specializing in nursing with extensive expertise in patient safety and burn survivor care. With a doctorate from Shahid Beheshti University, her research spans qualitative studies in nursing, including the impact of COVID-19 on healthcare professionals and home care efficacy for burn survivors. Dr. Heydarikhayat has authored numerous articles in reputable journals and collaborated internationally on healthcare innovations. Recognized for her contributions, she continues to lead impactful research projects, demonstrating dedication to advancing nursing education and patient care. 🌐✨

Publication profile

Google Scholar

Academic and Professional Background

With a Ph.D. in nursing from Shahid Beheshti University, Heydarikhayat’s career includes impactful research on patient safety and burn survivor care. 🏥

Research Focus

Nastaran Heydarikhayat’s research spans diverse areas within nursing, emphasizing qualitative and quantitative studies focused on patient care and healthcare systems. 🏥 Her notable contributions include studies on burn survivor care, patient safety, and the psychological impacts of home care interventions. Through extensive clinical trials and qualitative analyses, Heydarikhayat has explored topics such as nurse-patient interactions during triage, coping strategies among medical students, and the lived experiences of nurses caring for COVID-19 patients. Her work not only enhances understanding in these critical areas but also contributes significantly to improving healthcare practices and policies. 🌟

Publication Top Notes

Effect of telenursing and face-to-face training techniques on quality of life in burn patients: a clinical trial📊 Cited by: 47, Year: 2020
Assessing stressors and coping styles in medical sciences students🧠 Cited by: 40, Year: 2012
Effect of post-hospital discharge follow-up on health status in patients with burn injuries: a randomized clinical trial 🏥 Cited by: 37, Year: 2018
Assessing patient safety events and it’s correlation with nurse-physician interaction from nurses’ view 👩‍⚕️ Cited by: 34, Year: 2012
Primiparous women’s experiences of normal vaginal delivery in Iran: a qualitative study 🤰 Cited by: 29, Year: 2020
Correlation of revised trauma score with mortality rate of traumatic patients within the first 24 hours of hospitalization 🚑 Cited by: 19, Year: 2014
Nurses’ lived experiences of caring for patients with COVID-19: a phenomenological study 🩺 Cited by: 18, Year: 2022
Home care for burn survivors: a phenomenological study of lived experiences 🏠 Cited by: 16, Year: 2021
Effect of triage training on concordance of triage level between triage nurses and emergency medical technicians 🚨 Cited by: 16, Year: 2016
Assessing frequency and causes of verbal abuse against the clinical staff🗣️ Cited by: 15, Year: 2012

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Posted on 10/06/202410/06/2024 by ScienceFather

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Dr Jianglan Long,Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University,China

Dr. Jianglan Long is a dedicated Researcher Intern at Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital and Capital Medical University. Specializing in intelligent molecular diagnostics and drug intervention mechanisms for pre-diabetes and type 2 diabetes, Dr. Long has published several impactful papers. Notable works include studies in International Journal of Biological Macromolecules (2024) on innovative diabetes treatments, and contributions to Diabetes Obesity & Metabolism (2024) on predictive biomarker profiling. Dr. Long is a pioneer in developing integrated diagnostic tools and advancing diabetes treatment in China. 🌟🔬📚

Publication profile

Scopus

Academic and Professional Background

Dr. Jianglan Long is a prominent researcher based at the Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital, Capital Medical University. His primary focus lies in the exploration of intelligent molecular diagnosis and drug intervention mechanisms for prediabetes and type 2 diabetes. Dr. Jianglan Long has made significant contributions to this field, evidenced by his publications in reputable journals such as the International Journal of Biological Macromolecules (2024), Diabetes Obesity & Metabolism (2024), Clinical and Translational Medicine (2021), BMC Endocrine Disorders (2020), and Rapid Communications in Mass Spectrometry (2020), where he served as the first author.

Research focus

Category: Research Focus on Intelligent Molecular Diagnosis and Drug Intervention for Diabetes

Jianglan Long’s research centers on advancing the field of intelligent molecular diagnostics and drug interventions for pre-diabetes and type 2 diabetes. Her work includes pioneering biomarker profiling for early disease detection and the enhancement of metformin therapy with innovative treatments, like low molecular weight polysaccharides from Astragalus membranaceus. With twelve published journals and ongoing research, her contributions are crucial for improving diabetes management and treatment outcomes in China and potentially worldwide. 📊🔬💊🌍

Publication top notes

Structural characterization of Astragalus polysaccharide-D1 and its improvement of low-dose metformin effect by enriching Staphylococcus lentus

Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation

Rapid multichannel fluorescent probe assay for CYP450 inhibition screening and drug interaction monitoring

Novel weight loss diet attenuates dietary-induced obesity in mice and might correlate with altered gut microbiota and metabolite profiles

Polystyrene microplastic exposure induces insulin resistance in mice via dysbacteriosis and pro-inflammation

Evaluation of interaction of chlorogenic acid and cefotaxime sodium based on sequential analysis

Network pharmacology-based dissection of the underlying mechanisms of dyspnoea induced by zedoary turmeric oil

Metabolomics based plasma biomarkers for diagnosis of oral squamous cell carcinoma and oral erosive lichen planus

Dan Yan | Medicine and Dentistry | Best Researcher Award

Posted on 10/06/202410/06/2024 by ScienceFather

Dan Yan | Medicine and Dentistry | Best Researcher Award

Prof Dan Yan,Beijing Friendship Hospital, Capital Medical University,China

Prof. Dan Yan, Ph.D., is a leading figure in clinical pharmacy and precision medicine at Beijing Institute of Clinical Pharmacy, China. 🌟 With a robust background in traditional Chinese medicine and a Ph.D. from Chengdu University, he specializes in intelligent molecular diagnosis and combined medication for chronic metabolic diseases. 🧬 His groundbreaking research focuses on optimizing diabetes treatment, particularly exploring multi-drug combinations and personalized therapies. As a prolific author and committee member of prestigious scientific organizations, Prof. Yan is dedicated to advancing healthcare through innovative research and evidence-based practices. 📚✨

Publication profile

Scopus

Education

Prof. Dan Yan pursued an extensive educational journey at Chengdu University of Traditional Chinese Medicine, culminating in a Ph.D. from 2004 to 2007. Prior to his doctoral studies, he obtained his Master of Science degree from the same institution between 2001 and 2004. Prof. Yan’s academic pursuits trace back to his undergraduate years, where he completed his Bachelor of Science degree from 1994 to 1998, laying the foundation for his subsequent advanced studies. His educational background reflects a dedicated commitment to traditional Chinese medicine, fostering a deep expertise in this field.

Research focus

Prof. Dan Yan’s research focuses on the intelligent molecular diagnosis and combined medication for chronic metabolic diseases, particularly pre-diabetes and type 2 diabetes. His work leverages multi-omics approaches, such as metabolomics, to enhance early diagnosis and personalized treatment strategies. He aims to optimize drug combinations from a broad range of hypoglycemic drugs, including traditional and novel therapies. This research not only addresses the declining efficacy of long-term metformin use but also integrates pharmacoeconomics and evidence-based medicine to improve clinical outcomes in diabetes care.